FDA Brief

Warning letters Drugs

FDA warning letter to

Elle Pharm

High riskIssued Nov 3, 2025Posted Nov 5, 2025Center for Drug Evaluation and Research (CDER)

FDA warned Elle Pharm that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.

What happened

FDA reviewed the website www.ellepharm.com and observed that it offers unapproved and misbranded injectable botulinum toxin drug products for sale to U.S. consumers. FDA cited "Hutox 100ui" and "Hutox 100" as an example and noted website claims for "blepharospasm correction" and "hyperhidrosis." FDA said there are no approved applications for these Hutox products.

What FDA found

  1. FDA says the website offers a new drug without an approved FDA application, so it is unapproved and cannot be legally sold in interstate commerce.

    FD&C Act sections 301(d) and 505(a) [21 U.S.C. §§ 331(d), 355(a)]
  2. FDA says the labeling lacks adequate directions for use by a layperson, making the drug misbranded.

    FD&C Act section 502(f)(1) [21 U.S.C. § 352(f)(1)]
  3. FDA says the product is a prescription drug that is not safe for use except under a licensed practitioner's supervision.

    FD&C Act section 503(b)(1) [21 U.S.C. § 353(b)(1)]

What FDA wants

FDA asks Elle Pharm to stop offering any unapproved and misbranded drugs for sale to U.S. consumers and to review its websites, product labels, and promotional materials. It asks for a written response within 15 working days describing corrective steps, how recurrence will be prevented, and related documentation.

Who should pay attention

  • companies selling injectable aesthetic drugs online
  • U.S. clinicians who buy or administer botulinum toxin
  • consumers considering online botulinum toxin purchases

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk